The clinical significance of this peptidase in cancers has been recently highlighted by its membership as a cancer signature gene in a six-gene model, which has been demonstrated to have diagnostic and prognostic value in breast and lung cancers [26]. This evidence concerns the gene LAP3 and cancer.